Meeting
2013 Genitourinary Cancers Symposium
Postchemotherapy retroperitoneal lymph node dissection for advanced germ cell tumors at a Japanese single high-volume center.
Authors
Terukazu Nakamura
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Terukazu Nakamura , Yasunori Kimura , Takashi Ueda , Yoshio Naya , Fumiya Hongo , Tsuneharu Miki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer
Sub Track
Penile, Urethral, and Testicular Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 331)
DOI
10.1200/jco.2013.31.6_suppl.331
Abstract #
331
Poster Bd #
K6
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.
First Author: Bendu Konneh
First Author: Suliman Boulos
Poster
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
First Author: Ahmed Bilal Khalid
Poster
2023 ASCO Genitourinary Cancers Symposium
Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy.
First Author: Ciara Conduit